PHIO PHARMACEUTICALS CORP (PHIO) Stock Income Statement
NASDAQ:PHIO - Nasdaq - US71880W5013 - Common Stock - Currency: USD
| 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 20.00K | |||
| Operating Expenses | 10.70M | 11.46M | 13.51M | 8.79M | 9.01M | |||
| Research and Development | 6.33M | 7.01M | 8.89M | 4.43M | 4.30M | |||
| Selling, General, and Administrative Expenses | 4.37M | 4.45M | 4.63M | 4.36M | 4.71M | |||
| Operating Income | -10.70M | -11.46M | -13.51M | -8.79M | -8.99M | |||
| Interest Income/Expense | N/A | N/A | -10.00K | N/A | N/A | |||
| Other Income/Expense | -2.00K | -20.00K | N/A | 0.00 | 80.00K | |||
| Non Recurring Items | -126.00K | N/A | 230.00K | N/A | N/A | |||
| Income Before Taxes | -10.83M | -11.48M | -13.29M | -8.79M | -8.91M | |||
| Income Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Net Income | -10.83M | -11.48M | -13.29M | -8.79M | -8.91M | |||
| EBITDA | -10.51M | -11.39M | -13.43M | -8.72M | -8.92M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -5.20 | -10.07 | -12.43 | -23.13 | -222.75 | |||
| Non GAAP EPS | N/A | -90.72 | N/A | N/A | N/A | |||
| Statistics | ||||||||
| Profit Margin | N/A | N/A | N/A | N/A | -44550.00% | |||
| Operating Profit Margin | N/A | N/A | N/A | N/A | -44950.00% | |||
All data in USD